Ken Haruma

Appearances

CLINICAL DIFFERENCES OF PATIENTS WITH LOWER GASTROINTESTINAL BLEEDING BETWEEN IN-PATIENT AND OUT-PATIENT ONSET IN A 1,952 JAPANESE PATIENT COHORT.
Date
May 9, 2023
BACKGROUND: Biological treatment in inflammatory bowel disease (IBD) patients is currently hampered by high non-response rates. To enhance personalized medicine and predict response to biological therapeutics such as vedolizumab, the working mechanism should be elucidated…
Presenter
Minoru Fujita
Speakers
Noriaki Manabe
Takahisa Murao
Mitsuhiko Suehiro
Ryo Katsumata
Maki Ayaki
Hirofumi Kawamoto
Akiko Shiotani
Jiro Hata
Ken Haruma
ELOBIXIBAT, A BILE ACID TRANSPORTER INHIBITOR, SIGNIFICANTLY IMPROVES RECTAL SENSORY THRESHOLDS IN ELDERLY PATIENTS WITH CHRONIC CONSTIPATION: A RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Date
May 7, 2023
BACKGROUND: The gastrointestinal (GI) disturbance is a frequent complication in patients with thoracolumbar vertebral fracture (TVF), especially in the postoperative period. Laxatives are sometimes of limited effect…
Presenter
Noriaki Manabe
Speakers
Maki Ayaki
Minoru Fujita
Minami Umeyama
Sonoko Ishizaki
Takumi Ota
Shinji Kuratani
Ryo Katsumata
Naoki Sumi
Ken Haruma
ELOBIXIBAT, A BILE ACID TRANSPORTER INHIBITOR, SIGNIFICANTLY IMPROVES STOOL AND/OR GAS DISTRIBUTION THROUGH TOTAL FECAL BILE ACIDS IN ELDERLY PATIENTS WITH CHRONIC CONSTIPATION: A RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Date
May 20, 2024
BACKGROUND AND AIM: Bowel stools and/or gas (S/G) volume were reported to be important indicators of bowel function in patients with chronic constipation (CC)…
Presenter
Noriaki Manabe
Speakers
Emiko Bukeo
Takako Konishi
Ryo Katsumata
Maki Ayaki
Minoru Fujita
Ken Haruma